Related Experiment Video
Updated: Mar 2, 2026
07:49
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
3.3K
Metabolic Reprogramming and Oncogenesis: One Hallmark, Many Organelles
1Medical Research Council Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, ENG, United Kingdom.
International Review of Cell and Molecular Biology
|May 21, 2017
Summary
Cancer cells rewire metabolism to meet energy demands, utilizing organelles beyond mitochondria. This review explores how lysosomes, peroxisomes, and endoplasmic reticulum contribute to cancer metabolic reprogramming.
Area of Science:
- Cellular Biology
- Biochemistry
- Oncology
Background:
- Tumorigenesis involves significant metabolic alterations to support rapid cancer cell proliferation.
- Cancer cells adapt their metabolism to survive in nutrient-poor, hypoxic tumor microenvironments.
- While mitochondrial function reprogramming is well-studied, the roles of other organelles are less understood.
Purpose of the Study:
- To review the metabolic functions of non-mitochondrial organelles in cancer.
- To elucidate the contribution of organelles like lysosomes, peroxisomes, and endoplasmic reticulum to cancer metabolic reprogramming.
- To explore the communication networks between these organelles in cancer transformation.
Main Methods:
- Literature review of current research on cancer metabolism.
- Analysis of metabolic functions within lysosomes, peroxisomes, and endoplasmic reticulum.
- Synthesis of information on organelle communication and its role in tumorigenesis.
Main Results:
- Dysregulation of glucose, glutamine, and lipid metabolism are key cancer-associated metabolic changes.
- Lysosomes, peroxisomes, and endoplasmic reticulum are integral to cellular metabolic networks.
- These organelles exhibit altered functions in cancer cells, contributing to metabolic reprogramming.
Conclusions:
- Non-mitochondrial organelles play crucial, yet underappreciated, roles in cancer metabolism.
- Understanding organelle crosstalk is vital for comprehending coordinated metabolic reprogramming in cancer.
- Targeting these organelles may offer novel therapeutic strategies for cancer treatment.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:22PI3K/mTOR/AKT Signaling Pathway
5.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.9K
01:14Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
01:19Regulation of Metabolism
11.9K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.9K
02:21Cancers Originate from Somatic Mutations in a Single Cell
15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K